Emphysema – a severe form of Chronic Obstructive Pulmonary Disease (COPD) – is a progressive disease that traps air in the air sacs in the lungs (alveoli) and causes hyperinflation, which makes it difficult to expel air from the lungs.
Selection criteria for the Zephyr Valve therapy include patients who:
- Have a history of smoking.
- Are symptomatic and experience persistent shortness of breath, despite optimal medication (inhalers).
- Have a FEV1 of <59% on a spirometry test.
Refer to a Zephyr Endobronchial Valve Treating Physician at one of our partnering hospitals. Your patient will undergo further lung function assessments to determine suitability for Zephyr Valves.
What is the Zephyr Endobronchial Valve?
The Zephyr Valve is a tiny valve designed to reduce hyperinflation. The valve blocks airflow to the diseased region of the lung to allow the healthy region to expand and function more efficiently, resulting in improved breathing and quality of life.
HEALTHCARE PROFESSIONAL USE ONLY
Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, haemoptysis, pneumonia, dyspnoea and, in rare cases, death.